Transarterial chemoembolization combined with sorafenib for advanced hepatocellular carcinoma

Sorafenib has been demonstrated to improve survival rate in patients with advanced hepatocellular carcinoma (HCC); however, the survival benefit remains modest and the response rates remain poor. Transarterial chemoembolization (TACE) may be used for the treatment of advanced HCC with well-preserved...

Descripción completa

Detalles Bibliográficos
Autores principales: SHAO, WENBO, ZHANG, FENGJUAN, CONG, NING, LI, JINPENG, SONG, JINLONG
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2014
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4186530/
https://www.ncbi.nlm.nih.gov/pubmed/25289106
http://dx.doi.org/10.3892/ol.2014.2512

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4186530/
https://www.ncbi.nlm.nih.gov/pubmed/25289106
http://dx.doi.org/10.3892/ol.2014.2512

Ejemplares similares